ArticleOPEN ACCESS

How Tysabri survived

Nature Biotechnology
DOI: 10.1038/nbt1109-986
9Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Most drugs withdrawn from the market because of serious toxicities never make it back. But Biogen Idec succeeded in getting its multiple sclerosis (MS) drug Tysabri reintroduced in less than 16 months.

Cite

CITATION STYLE

APA

Huggett, B. (2009, November). How Tysabri survived. Nature Biotechnology. https://doi.org/10.1038/nbt1109-986

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free